iifl-logo

Brooks Laboratories Ltd Share Price

117.43
(6.03%)
Apr 2, 2025|11:09:58 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open112.12
  • Day's High121.56
  • 52 Wk High198.86
  • Prev. Close110.75
  • Day's Low106.41
  • 52 Wk Low 73.25
  • Turnover (lac)61.61
  • P/E165
  • Face Value10
  • Book Value27.05
  • EPS0.67
  • Mkt. Cap (Cr.)308.22
  • Div. Yield0
View All Historical Data
No Records Found

Brooks Laboratories Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

112.12

Prev. Close

110.75

Turnover(Lac.)

61.61

Day's High

121.56

Day's Low

106.41

52 Week's High

198.86

52 Week's Low

73.25

Book Value

27.05

Face Value

10

Mkt Cap (₹ Cr.)

308.22

P/E

165

EPS

0.67

Divi. Yield

0

Brooks Laboratories Ltd Corporate Action

18 Jul 2023

12:00 AM

Rights

arrow

19 Dec 2024

12:00 AM

EGM

arrow

2 Sep 2024

12:00 AM

AGM

Announcement Date: 02 Sep, 2024

arrow

10 Feb 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

2 Sep 2024

12:00 AM

BookCloser

arrow

Brooks Laboratories Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Brooks Laboratories Ltd SHAREHOLDING SNAPSHOT

02 Apr, 2025|11:36 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 52.61%

Foreign: 0.00%

Indian: 52.61%

Non-Promoter- 9.90%

Institutions: 9.90%

Non-Institutions: 37.47%

Custodian: 0.00%

Share Price

Brooks Laboratories Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

26.25

24.7

24.7

24.7

Preference Capital

0

0

0

0

Reserves

43.28

32.08

40.3

39.51

Net Worth

69.53

56.78

65

64.21

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

77.24

69.68

55.71

57.53

yoy growth (%)

10.84

25.08

-3.17

-28.08

Raw materials

-47.47

-46.82

-39.37

-36.66

As % of sales

61.45

67.19

70.67

63.71

Employee costs

-14.36

-13.38

-11.8

-8.25

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

-8.43

-13.51

-17.53

2.48

Depreciation

-7.09

-6.64

-6.44

-1.67

Tax paid

-7.15

-10.86

3.72

-0.81

Working capital

-1.12

6.26

0.96

-6.78

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

10.84

25.08

-3.17

-28.08

Op profit growth

-119.47

-55.87

-276.31

-54.51

EBIT growth

-47.44

-32.66

-532.2

-69.59

Net profit growth

-36.05

76.47

-928.65

-84.32

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021

Gross Sales

79.49

63.2

91.08

77.25

Excise Duty

0

0

0

0

Net Sales

79.49

63.2

91.08

77.25

Other Operating Income

0

0

0

0

Other Income

0.96

0.57

0.91

0.74

Brooks Laboratories Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,698.35

129.244,07,155.151,181.050.85,985.3398.33

Divis Laboratories Ltd

DIVISLAB

5,549.7

71.051,47,295.245940.542,297513.62

Cipla Ltd

CIPLA

1,444.25

25.071,16,664.331,438.150.94,134.87360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,183.9

59.031,07,673.274850.882,330222.38

Mankind Pharma Ltd

MANKIND

2,458.1

52.421,01,358.17416.3802,396.57334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Brooks Laboratories Ltd

Management

Register Office

Registrar Office

Whole Time Director

Jitendra Pratap Singh

Whole-time Director

Durga Sankar Maity

Whole-time Director

Mr. Bhushan Singh Rana

Independent Director

Lalit Mahajan

Independent Director

Usha Singh

Independent Director

Manav Mahajan

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Brooks Laboratories Limited was incorporated on January 23, 2002. The company was initially promoted for manufacturing latest molecules in Injectables, tablets and dry syrups for the domestic customers. Brooks Laboratories is a pharmaceutical manufacturing company working on contract basis. The company has manufacturing plants at Baddi, Himachal Pradesh and Vadodara, Gujarat. Both the units are cGMP compliant in conformity with national and international standards. The Vadodara facility of the company has been approved by European Medicine agency. The company has a wide range of products catering to critical care segment in Parental Section like Beta Lactam, Cephalosporin & General Dry powder Injectables, Ampoules and Liquid vials, Dry Syrups and Tablets etc. Their product portfolio presently comprises of 28 Injectables, 19 Tablets and 2 Dry Syrups which are marketed domestically.The companys manufacturing facilities are designed to manufacture a variety of products in the formulation segment using a combination of processes. At Baddi, they manufacture wide range of products under the formulation segment for various top notch companies of India.The companys major clients are companies like Zydus Cadila, Aristo Pharmaceuticals Pvt Ltd, FDC Ltd, Nectar Lifesciences Ltd, Sanat Products Ltd, Hetero Healthcare Ltd, Medley Pharmaceuticals, Wockhardt Ltd, Parental Drugs, Chanderbhagat Pharma and Alembic Ltd etc. Their major suppliers of raw materials are Rajasthan Antibiotics Ltd, A
Read More

Company FAQs

What is the Brooks Laboratories Ltd share price today?

The Brooks Laboratories Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹117.43 today.

What is the Market Cap of Brooks Laboratories Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Brooks Laboratories Ltd is ₹308.22 Cr. as of 02 Apr ‘25

What is the PE and PB ratio of Brooks Laboratories Ltd?

The PE and PB ratios of Brooks Laboratories Ltd is 165 and 4.13 as of 02 Apr ‘25

What is the 52 Week High and Low of Brooks Laboratories Ltd?

The 52-week high/low is the highest and lowest price at which a Brooks Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Brooks Laboratories Ltd is ₹73.25 and ₹198.86 as of 02 Apr ‘25

What is the CAGR of Brooks Laboratories Ltd?

Brooks Laboratories Ltd's CAGR for 5 Years at 47.52%, 3 Years at 8.54%, 1 Year at 13.13%, 6 Month at -26.90%, 3 Month at -39.72% and 1 Month at 3.44%.

What is the shareholding pattern of Brooks Laboratories Ltd?

The shareholding pattern of Brooks Laboratories Ltd is as follows:
Promoters - 52.62 %
Institutions - 9.90 %
Public - 37.48 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.